Marisa Benner Email & Phone Number

Wilmington, Delaware, United States

Neuroscience Business Unit (Shire Is Now Part Of Takeda) DE And E. Shore Of MD

• 2021: 1/67 Selected as DE&I Local Field Ambassador for Mid-Atlantic Region
• 2020: Appointed for round table discussion with National Sales Director
• 2019: Cresset Winner (Top 4% Nation) Ranked #13/301
• 2019: Won Max Impact Award for Q1 2019, Vyvanse Goal Attainment of 101%
• Achieved Specialty position for Neuroscience Psychiatry sales force - drive growth of Vyvanse, Mydayis, and Trintellix
• Earned Regional Managed Care Lead Position, created managed care grids that were shared regionally and across the East Area

DE And Eastern Shore Of MD

• 2018: Top 2% #9/494 for Mydayis TRx growth within 12 months of launch & Top 4% #18/494 Vyvanse MS 25.8%, Top 6% #29/494 Vyvanse MS Growth 0.8%
• 2018: 1/110 in Zone selected to participate on Vyvanse Brand Team strategy session, #1 Vyvanse MS in Zone 26.1%
• 2017: MVP Award - Recognized by Peers and Manager for Team Leadership and Efficiency in Business Analytics
• 2016: Top 11% #20/188 at Year End, Exceeded Vyvanse Goal Attainment 3 out of 4 Quarters
• 2015: Achieved Vyvanse Goal Attainment of 111% during launch of Binge Eating Disorder
• 2014: PRESIDENT'S CLUB Winner (Top 5% Nation) Ranked #4/391

DE And Eastern Shore Of MD

• 2012: Awarded Q4 Representative of the Quarter – Vyvanse Goal Attainment = 101% & Intuniv Goal Attainment = 122%
• 2011: Secured #1/520 Rank for Q1 Vyvanse Goal Attainment = 116% & Intuniv Goal Attainment = 125%
• 2010: Achieved #1/569 Rank for Intuniv within 12 months of launch
• 2009: Consecutively (3 Quarters) Ranked Top 5% for Vyvanse Market Share Growth #8,17,27/569
• Repeatedly selected by key leaders to support ongoing development of sales force, initiating cross-regional conference calls to coordinate strategies and align strategic initiatives, as well as helping with the.
• Awarded Representative of the Quarter: Q2 2010, Q3 2010, Q1 2011, Q4 2012.

DE And Eastern Shore Of MD

• 2008: Top 2% Ranked #10/569 for Vyvanse Market Share Growth (5.1%) within 18 months of launch
• 2007: Awarded Q1 Representative of the Quarter – Ranked #14/444 Daytrana MS Growth and #38/444 Adderall XR MS
• 2007: Top 3% #14/444 for Daytrana Market Share growth within 9 months of launch
• Awarded Representative of the Quarter: Q4 2008, Q1 2007.
• Spurred outstanding growth in market share each year to outperform region, zone, and nation trends; in one year, achieved top 28% growth rank for Vyvanse and top 12% (#68/569) for Daytrana.
• Effectively transitioned patients from established and competitor product lines to rank in top-10 position (#10/569) for Vyvanse (17.3% market share) within 18 months of launch.

DE And Eastern Shore Of MD

• 2005: Top 3% in Nation #12/366 for Adderall XR Market Share 37.5% (Growth of 1.1%).
• Played key role in leading Adderall XR market share to all-time high (38.9%) and contributing to top ranking performance year after year.
• Selected as Sales Trainer for CNS Initial Sales Training Class (new hires).
• Leadership Award Q1 2006 and Q4 2005.

Pittsburgh, PA

• Established reputation for advancement and driving year-over-year profitability for multiple product lines of global leader in beverage distribution.
• Promoted to manage territory encompassing 475 on-premise customers and 350K+ units with accountability for ensuring 2% growth each year.
• Sourced new prospects, engaged key decision makers, presented value add, and negotiated contracts to secure new revenue streams.
• Analyzed competitor positioning and effectively addressed challenges to maximize market share.
• Administered $50K supply budget.
• As New Business Sales Representative, marketed beverage programs within 1500 account territory.

Bachelor Of Science, International Business And Business Logistics, Minors: French And International Studies

Education record